Current Market Update

From Cabot Top Ten Trader It’s been a relatively choppy week, with Monday seeing many major indexes briefly sinking to new lows before reversing higher, a modest bounce mid-week, and this morning looking like another sharp drop. Following the open, it appears the S&P 500 be...
Read More

Cabot Emerging Markets Investor 674

We’re not going to say emerging market stocks are showing any real strength, but there are a few encouraging signs out there—the iShares EM Fund (EEM) has stopped underperforming U.S. markets during the past couple of months, and even during the selloff of past...
Read More

Cabot Growth Investor 1408

Sellers Still Lurking The first three and a half weeks of October were brutal, with the S&P 500 (down 11%) and Nasdaq (down 14%) cascading significantly, turning both our Cabot Tides and Cabot Trend Lines bearish as we raised a boatload of cash. But those...
Read More

Cabot Undervalued Stocks Advisor 1218

Another Dow 30 Shakeup is Coming November brought some significant news about General Motors (GM) and United Technologies (UTX), while General Electric (GE) continues to invite investor inquiries. As our portfolio stocks experience share price recoveries alongside the broader market, in the aftermath of October...
Read More

Cabot Emerging Markets Investor 673

We’re not going to say emerging market stocks are showing any real strength, but there are a few encouraging signs out there—the iShares EM Fund (EEM) has stopped underperforming U.S. markets during the past couple of months, and even during the selloff of past...
Read More

Cabot Marijuana Investor 1118

Is the Correction Over? Part 2   The good news is that the cannabis industry in North America is booming. Legal recreational sales in Canada are very healthy, with the only problem being a supply shortage—which will be alleviated in the months ahead. And legal continues...
Read More